Phase I safety and immunogenicity studies of Peru 15, a live attenuated oral vaccine candidate for Vibrio cholerae 01 in Bangladeshi volunteers, both adults and children
Download
Adobe PDF
(2.66 MB)
Adobe PDF
(2.66 MB)